|
Orthologous residues
|
|
ENaC‑alpha (human): T663‑p, ENaC‑alpha (mouse): A692‑p, ENaC‑alpha (rat): A692‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, western blotting
|
|
Relevant cell lines - cell types - tissues:
oocyte
|
|
Cellular systems studied:
primary cells
|
|
Species studied:
frog
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
phorbol ester
|
|
|
|
decrease
|
Phorbol ester caused decrease in expression of T663 and A663 in oocytes.
|
|
calphostin C
|
|
|
|
decrease
|
Calphostiin C decreases T663 expression, but not A663.
|
|
|
Downstream Regulation
|
|
Comments:
PKC delta may affect rate of biosynthesis or delivery of T663 to the plasma membrane, but not by direct phosphorylation of T663.
|